Given the positive effects of CTRP9 on T-cell immunity, it is unsurprising that we observed CTRP9 enhancing the cytokine production and cytotoxicity of anti-CD19 CAR-T cells in mice, thereby facilitating a more efficient eradication of CD19+ B-cell lymphoma. This evidence concerns the gene CD19 and B-cell non-Hodgkin lymphoma.